DRP Journal

Discover Research Profit

Finance 

CTT Pharmaceutical Holdings Inc. (OTC:CTTH) Announces OTCQB Uplisting

Ian Leigh

The uplisting to a bigger exchange with greater exposure to a larger pool of investors is certainly a positive for any company, and hence, CTT Pharmaceutical Holdings Inc. (OTC:CTTH) could be the one to follow this morning in light of the announcement made by the company yesterday. In this feature, we will take a closer look into it.

OTCQB Uplisting

In the news release yesterday, the company announced that its shares of the common stock had been approved by the OTC Markets Group for trading on the OTCQB Market. CTT Pharmaceutical Holdings also revealed that the stock will trade under the ticker symbol CTTH once the markets open for trading on March 10, 2025. The latest development could be a significant one for CTT Pharmaceutical Holdings, and it is going to be interesting to see if it leads to greater attention for the stock or not.

Further Information

The company also noted that OTCQB would provide the CTT Pharmaceutical Holdings stock with higher liquidity, and the United States-based shareholders would also get a smoother trading experience. The listed companies on the exchange are current in terms of their reporting and also go through yearly PCAOB audits.

Ian Leigh

Ian Leigh is a specialist in analyzing stocks, SEC and OTC filings, and financials of public and privately-held companies. He has played a significant role in M&A activity, consulting with publicly-held firms on acquisitions and divestitures. He also consults on valuations and branding. He lectures at major universities and teaches at specialty financial schools.